Literature DB >> 23883234

The role of PET/CT in the management of cervical cancer.

Sahar Mirpour1, Joyce C Mhlanga, Prashanti Logeswaran, Gregory Russo, Gustavo Mercier, Rathan M Subramaniam.   

Abstract

OBJECTIVE. Cervical cancer is the second most common malignancy in women worldwide and the third most common cause of cancer mortality in the United States. The aim of this article is to describe cervical cancer and outline the value of (18)F-FDG PET/CT in the management of cervical malignancy. CONCLUSION. The value of PET/CT has been found in staging and treatment strategy for cervical cancer. FDG PET/CT facilitates decision-making and radiation treatment planning and provides important information about treatment response, disease recurrence, and long-term survival.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23883234     DOI： 10.2214/AJR.12.9830

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN： 0361-803X            Impact factor:   3.959


  19 in total

1.  Imaging modality utilization trends in patients with stage III-IV oropharyngeal squamous cell carcinoma.

Authors:  Yukako Ichimiya; Krishna Alluri; Charles Marcus; Simon Best; Christine H Chung; Rathan M Subramaniam
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-01-15

2.  Pretreatment metabolic tumour volume and total lesion glycolysis are not independent prognosticators for locally advanced cervical cancer patients treated with chemoradiotherapy.

Authors:  Ozan Cem Guler; Nese Torun; Berna Akkus Yildirim; Cem Onal
Journal:  Br J Radiol       Date:  2018-01-10       Impact factor: 3.039

Review 3.  Current imaging strategies for the evaluation of uterine cervical cancer.

Authors:  Charis Bourgioti; Konstantinos Chatoupis; Lia Angela Moulopoulos
Journal:  World J Radiol       Date:  2016-04-28

Review 4.  Recent Trends in PET Image Interpretations Using Volumetric and Texture-based Quantification Methods in Nuclear Oncology.

Authors:  Muhammad Kashif Rahim; Sung Eun Kim; Hyeongryul So; Hyung Jun Kim; Gi Jeong Cheon; Eun Seong Lee; Keon Wook Kang; Dong Soo Lee
Journal:  Nucl Med Mol Imaging       Date:  2014-01-22

Review 5.  [18F]-2-Fluoro-2-Deoxy-D-glucose-PET Assessment of Cervical Cancer.

Authors:  Chitra Viswanathan; Silvana Faria; Catherine Devine; Madhavi Patnana; Tara Sagebiel; Revathy B Iyer; Priya R Bhosale
Journal:  PET Clin       Date:  2018-02-03

6.  18F-FDG PET/CT Habitat Radiomics Predicts Outcome of Patients with Cervical Cancer Treated with Chemoradiotherapy.

Authors:  Wei Mu; Ying Liang; Lawrence O Hall; Yan Tan; Yoganand Balagurunathan; Robert Wenham; Ning Wu; Jie Tian; Robert J Gillies
Journal:  Radiol Artif Intell       Date:  2020-11-04

Review 7.  Positron emission tomography image-guided drug delivery: current status and future perspectives.

Authors:  Rubel Chakravarty; Hao Hong; Weibo Cai
Journal:  Mol Pharm       Date:  2014-06-04       Impact factor: 4.939

8.  Fluorodeoxyglucose positron-emission tomography-magnetic resonance hybrid imaging: An emerging tool for staging of cancer of the uterine cervix.

Authors:  Alina Nazir; Robert Matthews; Annapurneswara Rao Chimpiri; Melissa Henretta; Joyce Varughese; Dinko Franceschi
Journal:  World J Nucl Med       Date:  2020-08-22

9.  Correlation between histological grade and positron emission tomography parameters in cervical carcinoma.

Authors:  Vanessa Mocciaro; Paolo Scollo; Alessandro Stefano; Stefania Gieri; Giorgio Russo; Giuseppe Scibilia; Sebastiano Cosentino; Gabriella Murè; Sara Baldari; Maria Gabriella Sabini; Filippo Fraggetta; Maria Carla Gilardi; Massimo Ippolito
Journal:  Oncol Lett       Date:  2016-06-23       Impact factor: 2.967

10.  Differences between TNM classification and 2-[18F]FDG PET parameters of primary tumor in NSCLC patients.

Authors:  Paulina Cegla; Maciej Bryl; Kamila Witkowska; Agnieszka Bos-Liedke; Katarzyna Pietrasz; Witold Kycler; Julian Malicki; Tomasz Piotrowski; Rafał Czepczyński
Journal:  Rep Pract Oncol Radiother       Date:  2021-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.